Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Ridaforolimus)(8669-011 AM6)

PHASE3CompletedINTERVENTIONAL

Enrollment

711

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2010

Study Completion Date

December 31, 2012

Conditions

Metastatic Soft-Tissue SarcomasMetastatic Bone Sarcomas

Interventions

DRUG

ridaforolimus

Four 10 mg tablets taken by mouth for 5 days per week continuously

DRUG

Placebo

Four 10 mg tablets taken by mouth for 5 days per week continuously